Meclizine
Classification: BATC code: R06AE05
Summary
Published controlled studies on differences between men and women regarding safety and pharmacokinetics of meclozine/meclizine are lacking.
The present evidence concerning differences between men and women is very limited and do not motivate differentiation in dosing or treatment.
Additional information
Meclozine in English literature is known as meclizine.
Pharmacokinetics and dosing
No studies with a clinically relevant sex analysis regarding the pharmacokinetics of meclizine have been found.
Effects
No studies with a clinically relevant sex analysis regarding the effects of meclizine have been found.
Adverse effects
No studies with a clinically relevant sex analysis regarding adverse effects of meclizine have been found.
Reproductive health issues
Regarding teratogenic aspects, please consult Janusmed Drugs and Birth Defects (in Swedish, Janusmed fosterpåverkan).
Updated: 2020-08-28
Date of litterature search: 2016-12-13
References
- Läkemedelsstatistik. Stockholm: Socialstyrelsen. 2015 [cited 2016-12-19.] Socialstyrelsens statistikdatabas
Reviewed by: Mia von Euler
Approved by: Karin Schenck-Gustafsson